2025
|
Invention
|
Heterocyclic compound as ripk1 inhibitor. The present invention relates to a compound of formula ... |
2023
|
Invention
|
Heterocyclic compound as ripk1 inhibitor. The present invention relates to a compound, a pharmace... |
|
Invention
|
Crystal form of compound and preparation method therefor. The present invention relates to a crys... |
2022
|
Invention
|
Heterocyclic compound as bcl-2 inhibitor. Provided in the present invention are a heterocyclic co... |
2021
|
Invention
|
Novel compound as rearranged during transfection kinase inhibitor. The present invention relates ... |
2019
|
Invention
|
Heterocyclic compounds used as fgfr inhibitors. The present invention relates to a heterocyclic c... |
2018
|
Invention
|
Heterocyclic compounds as mnk inhibitors.
The present invention relates to a heterocyclic compou... |
|
Invention
|
Heterocyclic compound used as mnk inhibitor. The present invention relates to a heterocyclic comp... |
2017
|
Invention
|
Heterocyclic compound used as fgfr inhibitor. The present invention relates to a heterocyclic com... |